D.A. Davidson & Co. Viatris Inc Transaction History
D.A. Davidson & Co.
- $12.1 Billion
- Q4 2024
A detailed history of D.A. Davidson & Co. transactions in Viatris Inc stock. As of the latest transaction made, D.A. Davidson & Co. holds 22,610 shares of VTRS stock, worth $215,473. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,610
Previous 22,763
0.67%
Holding current value
$215,473
Previous $264,000
6.44%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding VTRS
# of Institutions
1,136Shares Held
986MCall Options Held
2.34MPut Options Held
2.21M-
Vanguard Group Inc Valley Forge, PA142MShares$1.35 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$883 Million0.02% of portfolio
-
State Street Corp Boston, MA63.7MShares$608 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$596 Million4.62% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD58.7MShares$559 Million0.08% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $11.6B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...